Injectable polysaccharide microcapsules for prolonged release of minocycline for the treatment of periodontitis

Biotechnol Lett. 2005 Nov;27(22):1761-6. doi: 10.1007/s10529-005-3550-7.

Abstract

Injectable polysaccharide microcapsules holding minocycline were fabricated from alginate and chitosan for the treatment of periodontitis. The microcapsules were examined for the release and degradation of minocycline, as well as antimicrobial activity. The microcapsules were biodegradable and released minocycline between 10 and 1000 microg ml(-1), which was higher than the usual therapeutic concentration (1-5 microg ml(-1)), for up to 7 days. These microcapsules showed a statistically significant suppression of pathogenic bacteria, such as Prevotella intermedia causing periodontitis. The microcapsules are thus potentially useful for drug delivery for the treatment of periodontitis.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Absorbable Implants
  • Capsules / administration & dosage
  • Capsules / chemistry
  • Diffusion
  • Drug Implants / administration & dosage*
  • Drug Implants / chemistry*
  • Humans
  • Injections
  • Minocycline / administration & dosage*
  • Minocycline / chemistry*
  • Periodontitis / drug therapy*
  • Periodontitis / microbiology
  • Polysaccharides / chemistry*
  • Treatment Outcome

Substances

  • Capsules
  • Drug Implants
  • Polysaccharides
  • Minocycline